The Patent Finder

Synpac (North Carolina), Inc.

Also on record
Records under this name other than the patents Synpac (North Carolina), Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 6 of 6 · Back to Synpac (North Carolina), Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,809,282A Method of Reducing Titers of Antibodies Specific for a Therapeutic Agent
Lapsed on the fee record
Ended Aug 19, 2026 · High confidence
Lapsed on the fee recordEnded Aug 19, 2026High confidence
US 7,056,712Treatment of Glycogen Storage Disease Type II
Term ended
Term ended Feb 26, 2023 · High confidence
Term endedTerm ended Feb 26, 2023High confidence
US 8,900,552Treatment of Glycogen Storage Disease Type II
Term ended
Term ended Jul 10, 2021 · Medium confidence
Term endedTerm ended Jul 10, 2021Medium confidence
US 9,370,556Treatment of Glycogen Storage Disease Type II
Term ended
Ended no later than Jul 10, 2021 · Low confidence
Term endedEnded no later than Jul 10, 2021Low confidence
US 9,907,839Treatment of Glycogen Storage Disease Type II
Term ended
Term ended Jul 10, 2021 · Medium confidence
Term endedTerm ended Jul 10, 2021Medium confidence
US 10,792,341Treatment of Glycogen Storage Disease Type II
Term ended
Term ended Jul 10, 2021 · Medium confidence
Term endedTerm ended Jul 10, 2021Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited